IgY-110

N/A

Report date: 2023/01/08 14:03:55

Base Information

Drug NameIgY-110
Drug Alias NameIgY-110
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIGY Life Sciences USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesIGY Life Sciences USA Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A